Treatments for Plaque Psoriasis

Plaque Psoriasis Management: Future Directions in Care
February 07, 2022

Closing out their discussion on the management of plaque psoriasis, panelists share their excitement for future directions in care.

Biologic Therapy in Plaque Psoriasis: Treating During the COVID-19 Pandemic
February 07, 2022

Experts reflect on the treatment of patients with plaque psoriasis during the COVID-19 pandemic.

Unmet Needs in Moderate to Severe Plaque Psoriasis Management
January 31, 2022

A brief discussion on the unmet needs and ongoing challenges in the treatment of plaque psoriasis.

Plaque Psoriasis Patient Case 2: Factors in Selecting 2L Therapy
January 31, 2022

Shared insight on which factors are most important in determining second-line therapy for plaque psoriasis.

Plaque Psoriasis Patient Case 2: Switching Therapy at Treatment Failure
January 24, 2022

Moving on to the second patient case, panelists discuss switching therapy at treatment failure for plaque psoriasis.

Factors in Selecting Biologic Therapy for Moderate to Severe Plaque Psoriasis
January 24, 2022

Panelists share which factors they use to determine optimal therapy in the moderate to severe plaque psoriasis setting.

Plaque Psoriasis: Biologic Therapy Toxicity Profiles
January 17, 2022

A panel of experts reflect on the toxicity profiles of biologic agents used to treat patients with plaque psoriasis.

Bimekizumab’s Potential in Moderate-to-Severe Plaque Psoriasis
January 17, 2022

A focused discussion on the benefit of bimekizumab, an IL-17A/IL-17F inhibitor, in the setting of moderate to severe plaque psoriasis.

Moderate to Severe Plaque Psoriasis: An Overview of Biologic Agents
January 10, 2022

A brief review of biologic agents being used or evaluated in the setting of plaque psoriasis.

Moderate to Severe Plaque Psoriasis: What is the Standard of Care?
January 10, 2022

Taking a broader look at moderate to severe plaque psoriasis, experts consider what the standard of care would be in different settings.